GenFlow Biosciences is a biotechnology company dedicated to increasing our understanding of the factors that controls lifespan. We research, develop and commercialize therapeutic solutions to lengthen healthspan, the amount of time we live in good health.
You may not know that only 3% of elephants get cancer. Surprising, right? A 7-ton mammal should produce many more cell divisions than smaller mammals, and so should generate more random mutations predisposing to cancer. So how do elephants elude cancer? Well, to start with, elephants don’t smoke, they walk all day, and they are vegetarians. But, above all else, the answer lies in their genome.
What sounds like the holy grail of medicine is the most serious goal of a young biotech company from Gosselies’ BioPark, GenFlow Biosciences. This small company, one of the last to have emerged in the carolo pole of life sciences, has embarked on the development of therapies to counter the effects of aging and diseases associated with old age.